Sotac Pharmaceuticals Ltd.

SOTAC

₹125.0

0% (0)

Market Cap

₹138 Cr.

P/E

17.21

About

Sotac Pharmaceuticals Limited specializes in the production of high-quality pharmaceutical products on a loan license or contract manufacturing basis. It has a diverse product portfolio that includes … Read more

Sotac Pharmaceuticals Limited specializes in the production of high-quality pharmaceutical pro… Read more

Low

52W Range

High

155

Timeline

Key company specific updates

Company Timeline

Subscribe now for more updates

Custom financial statementNew

Edit rows

Forensics

8 Yes

Positive for this company

3 Neutral

Neutral for this company

5 No

Negative for this company

1 No Data

Insufficient data to analyse

Accounting & Shareholding

Contingent Liabilities

Company does not have significant contingent liabilities
Depreciation Effect

Depreciation accounting is not leading to increase in profits
Other Income

Other income is not affecting ratios of the company
Pledge

Promoters have not pledged a significant portion of their holding
Retail Holding

Retail has been selling the stock which is usually a good time to buy
Promoter Holding

Promoter has not sold any shares in the last 90 days
Revenue Recognition

Chances of aggressive revenue recognition - operating profit of company is not getting converted to cash and recievables rising faster than sales

Price & Performance

ROE

Net profit margin is responsible for roe increase over last 10 years
Working Capital

Working capital of the company seems to be under control
Current vs Historic Valuation

Company is trading at a discount to 3yr historic valuations
Capex vs ROCE

Company has made significant capex which might be affecting its roce
Balance Sheet Strength

Balance sheet of the company is moderately strong
Share price

Share price has decreased over last 10 years more due to earnings
Debt

Company might have issues servicing its debt
Margin Stability

Margins of the company are volatile
ROCE Strength

Roce of the company is not consistently strong
Sales Growth

Unable to calculate due to limited data

Revenue mix

Product Wise Break-Up

Location Wise Break-Up

Peer Comparison

FAQs on Sotac Pharmaceuticals Ltd. Business

What does Sotac Pharmaceutical do?

Sotac Pharmaceuticals Limited offers high-quality pharmaceutical, nutraceutical, and food products through loan license or contract manufacturing. They serve corporate clients in this sector.

Who are the competitors of Sotac Pharmaceutical?

Sotac Pharmaceutical major competitors are Smruthi Organics, Tyche Inds, Bal Pharma, Denis Chem Lab, Mangalam Drugs&Org., Parnax Lab, Murae Organisor.
Market Cap of Sotac Pharmaceutical is ₹138 Crs.
While the median market cap of its peers are ₹138 Crs.

Is Sotac Pharmaceutical financially stable compared to its competitors?

Sotac Pharmaceutical seems to be less financially stable compared to its competitors.
Altman Z score of Sotac Pharmaceutical is 3.26 and is ranked 4 out of its 8 competitors.

View FAQ's On Shareprice

Global Leaders

Companies with a dominant global position in a product. Might be a sign of very strong moat.

Run Query

Reasonably Valued Domestic Healthcare Companies

Healthcare companies trading at a decent valuation

Run Query

Company Filing

	2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010
Annual Report	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11	FY10
Earnings Release
Investor Presentation
Conference Call
Conference Call SummaryCon Call Summary Powered by Gemini

Discussions & Analysis

Pharmaceutical Sector

How The Pharma Industry Works - PPFAS

Deep Dive into Pharma Sector - Omkara Capital

Pharma Compliance In-Depth - Amit Rajan

Nutraceuticals - The Next Gem of Healthcare Sector - Shuchi Nahar

Nutraceuticals- Industry Overview - Value Educator

Generic Opportunity for Indian Pharma Companies - Anish Moonka

Understanding the CDMO Sector - Will It Be The Next Megatrend - SOIC

Ideas Dashboard

Timeline

Watchlist

Portfolio

Alerts

Research

Stock Screener

Market

Raw Material

Sotac Pharmaceuticals Ltd.